Utah Life Sciences News & Events

biomerics

January 25, 2019

Recent News

PhotoPharmics to Present Patient Interest Findings from Groundbreaking Remote Parkinson’s Trial at PSG Annual Meeting
Fluidx Medical Begins Multinational Trial of GPX Embolic Device
Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease
Canary Speech Named to the 2024 CB Insights’ List of the 50 Most Innovative Digital Health Startups
Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma
Fluidx Medical Announces First Tumor Patient Treated in Prospective, Multinational Trial